全文获取类型
收费全文 | 9063篇 |
免费 | 499篇 |
国内免费 | 125篇 |
专业分类
耳鼻咽喉 | 119篇 |
儿科学 | 193篇 |
妇产科学 | 197篇 |
基础医学 | 1046篇 |
口腔科学 | 178篇 |
临床医学 | 1142篇 |
内科学 | 1388篇 |
皮肤病学 | 70篇 |
神经病学 | 702篇 |
特种医学 | 278篇 |
外科学 | 748篇 |
综合类 | 768篇 |
现状与发展 | 1篇 |
预防医学 | 1674篇 |
眼科学 | 168篇 |
药学 | 529篇 |
2篇 | |
中国医学 | 85篇 |
肿瘤学 | 399篇 |
出版年
2023年 | 135篇 |
2022年 | 224篇 |
2021年 | 332篇 |
2020年 | 320篇 |
2019年 | 290篇 |
2018年 | 274篇 |
2017年 | 293篇 |
2016年 | 299篇 |
2015年 | 306篇 |
2014年 | 554篇 |
2013年 | 814篇 |
2012年 | 481篇 |
2011年 | 532篇 |
2010年 | 400篇 |
2009年 | 453篇 |
2008年 | 466篇 |
2007年 | 459篇 |
2006年 | 348篇 |
2005年 | 314篇 |
2004年 | 273篇 |
2003年 | 210篇 |
2002年 | 194篇 |
2001年 | 157篇 |
2000年 | 133篇 |
1999年 | 126篇 |
1998年 | 118篇 |
1997年 | 99篇 |
1996年 | 76篇 |
1995年 | 82篇 |
1994年 | 74篇 |
1993年 | 74篇 |
1992年 | 65篇 |
1991年 | 52篇 |
1990年 | 48篇 |
1989年 | 45篇 |
1988年 | 35篇 |
1987年 | 34篇 |
1986年 | 57篇 |
1985年 | 63篇 |
1984年 | 57篇 |
1983年 | 28篇 |
1982年 | 48篇 |
1981年 | 31篇 |
1980年 | 41篇 |
1979年 | 31篇 |
1978年 | 25篇 |
1977年 | 24篇 |
1976年 | 17篇 |
1974年 | 14篇 |
1972年 | 11篇 |
排序方式: 共有9687条查询结果,搜索用时 15 毫秒
1.
2.
Defining con-founders that affect the reliability of diagnostic tests for coronavirus disease 2019 is vital to breaking the chain of infection. The elderly population is a higher risk group for the emerging virus. However, gender seems to exert a critical role in modifying the infection risk among women owing to hormonal changes. The menopause transition is an exceptional period for older women where the protective and immunomodulatory effects of the estrogen hormone are lost. Accordingly, attention should be given to postmenopausal women since they will have an increased risk compared to their pre-menopausal peers. 相似文献
3.
Zeyu Li Erwei Hao Rui Cao Si Lin Linghui Zou Tianyan Huang Zhengcai Du Xiaotao Hou Jiagang Deng 《中草药(英文版)》2022,14(4):479-493
Zedoary tumeric (Curcumae Rhizoma, Ezhu in Chinese) has a long history of application and has great potential in the treatment of liver cancer. The anti liver cancer effect of zedoary tumeric depends on the combined action of multiple pharmacodynamic substances. In order to clarify the specific mechanism of zedoary tumeric against liver cancer, this paper first analyzes the mechanism of its single pharmacodynamic substance against liver cancer, and then verifies the joint anti liver cancer mechanism of its "pharmacodynamic group". By searching the research on the anti hepatoma effect of active components of zedoary tumeric in recent years, we found that pharmacodynamic substances, including curcumol, zedoarondiol, curcumenol, curzerenone, curdione, curcumin, germacrone, β-elemene, can act on multi-target and multi-channel to play an anti hepatoma role. For example, curcumin can regulate miR, GLO1, CD133, VEGF, YAP, LIN28B, GPR81, HCAR-1, P53 and PI3K/Akt/mTOR, HSP70/TLR4 and NF-κB. Wnt/TGF/EMT, Nrf2/Keap1, JAK/STAT and other pathways play an anti hepatoma role. Network pharmacological analysis showed that the core targets of the "pharmacodynamic group" for anti-life cancer are AKT1, EGFR, MAPK8, etc, and the core pathways are neuroactive live receiver interaction, nitrogen metabolism, HIF-1 signaling pathway, etc. At the same time, by comparing and analyzing the relationship between the specific mechanisms of pharmacodynamic substance and "pharmacodynamic group", it is found that they have great reference significance in target, pathway, biological function, determination of core pharmacodynamic components, formation of core target protein interaction, in-depth research of single pharmacodynamic substance, increasing curative effect and so on. By analyzing the internal mechanism of zedoary tumeric pharmacodynamic substance and "pharmacodynamic group" in the treatment of liver cancer, this paper intends to provide some ideas and references for the deeper pharmacological research of zedoary tumeric and the relationship between pharmacodynamic substance and "pharmacodynamic group". 相似文献
4.
5.
6.
Platelets are needed to prevent or arrest bleeding and aggregate at the site of injury upon vascular damage. Platelets express receptors for estrogens which might affect the function of the platelets and their hemostatic ability. The aim was to identify possible differences in platelet function related to age, gender, and phases of the menstrual cycle by use of impedance aggregometry with Multiplate. In the first part of the study, platelet function was assessed in 60 healthy individuals (30 men and 30 women) in each of three age groups (20–25, 40–45, and 60–65 years). In the second part of the study, the platelet function was analyzed on four occasions during the menstrual cycle in women without oral contraceptives (OCs) (n = 17) and compared to 19 women on OCs and 18 men of similar age (20–40 years). For the women on OCs, aggregation was analyzed once during the tablet-free week and once late during the period with OCs. The men were sampled once. Women of younger age (<45 years) had significantly higher agonist-induced aggregation response than both men and post-menopausal women (60–65 years). The agonist-induced aggregation response did not differ between phases of the menstrual cycle or OC use. The results suggest that estradiol and/or progesterone affect spontaneous aggregation since it was found to be lowest in the mid-luteal phase. Spontaneous aggregation was significantly lower in women on OCs than in both men and women without OCs. Our findings indicate that fertile age is associated with higher aggregation response capacity of the platelets, possibly to prevent excessive bleeding during menstruation, but this response capacity is not altered during the menstrual cycle or by use of OCs. 相似文献
7.
8.
9.
10.